Pre-ANDA Program Update and Tips for Success – OPQ Perspective

preview_player
Показать описание
Fang Yuan, PhD, Office of Lifecycle Drug Products, discusses GDUFA-II pre-ANDA metrics and recommendations to prepare pre-ANDA development and submission meeting requests.
-------------------- 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  

Phone - (301) 796-6707 I (866) 405-5367
Рекомендации по теме